Evolv Technologies Holdings, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Stock Based Compensation (Tables)

Stock Based Compensation (Tables) - Evolv Technologies Holdings, Inc.

6 Months Ended

12 Months Ended

Jun. 30, 2021

Dec. 31, 2020

Schedule of fair value weighted-average assumptions


	Six Months Ended
	June 30,
	2021		2020
Risk-free interest rate	0.7	%	N/A
Expected term (in years)	6.0		N/A
Expected volatility	31.4	%	N/A
Expected dividend yield	0.0	%	N/A


	Year Ended December 31,
	2020		2019
Risk-free interest rate	0.4	%	2.5	%
Expected term (in years)	5.68		5.95
Expected volatility	31.4	%	27.9	%
Expected dividend yield	0.0	%	0.0	%

Summary of stock option activity

The following tables summarize the Company’s stock option activity since December 31, 2020 (in thousands, except for share and per share data):


				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Number of	Exercise		Contractual	Intrinsic
	Shares	Price		Term	Value
Outstanding as of December 31, 2020	49,679,554	$	0.14	8.24	$	1,073
Granted	17,130,123		0.16	9.53		49,335
Exercised	(5,523,538)		0.12	5.43		16,132
Exercised upon settlement of related party note	(3,888,889)		0.09	7.21		272
Forfeited	(223,875)		0.15	—		646
Outstanding as of June 30, 2021	57,173,375		0.15	8.46	$	165,295

Vested and expected to vest as of June 30, 2021	57,173,375	$	0.15	8.46	$	165,295
Options exercisable as of June 30, 2021	23,914,233	$	0.14	7.45	$	69,461

The following table summarizes the Company’s stock option activity since December 31, 2019 (in thousands, except for share and per share data):


				Weighted
		Weighted		Average
	Number of	Average		Remaining	Aggregate
	Shares	Exercise Price		Contractual Term	Intrinsic Value
				(in years)
Outstanding as of December 31, 2019	29,488,684	$	0.12	7.90	$	1,149
Granted	24,558,325		0.16	9.63		—
Exercised	(3,236,374)		0.14	6.60		75
Forfeited	(1,131,081)		0.15	—		14
Outstanding as of December 31, 2020	49,679,554	$	0.14	8.24	$	1,073

Vested and expected to vest as of December 31, 2019	29,488,684	$	0.12	7.90	$	1,149
Options exercisable as of December 31, 2019	15,663,415	$	0.11	7.28	$	817
Vested and expected to vest as of December 31, 2020	49,679,554	$	0.14	8.24	$	1,073
Options exercisable as of December 31, 2020	26,519,727	$	0.12	7.12	$	1,224

Schedule of stock-based compensation expense

Stock-based compensation expense was classified by award type in the consolidated statements of operations and comprehensive loss as follows (in thousands):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2021		2020		2021		2020
Stock options	$	264	$	60	$	467	$	122
Warrants		197		—		1,004		—
RSU's		74		—		146		—
Total stock-based compensation expense	$	535	$	60	$	1,617	$	122

Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):


	Year Ended December 31,
	2020		2019
Cost of revenue	$	10	$	2
Sales and marketing		104		170
General and administrative		370		74
Research and development		178		18
Total stock-based compensation expense	$	662	$	264